CSPC Innovation Pharmaceutical Co., Ltd. (SHE:300765)
China
· Delayed Price · Currency is CNY 30.07
-0.07 (-0.23%)
Apr 29, 2026, 11:25 AM CST
CSPC Innovation Pharmaceutical Company Description
CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally.
The company offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dyphylline, theobromine, pentoxifylline, and doxofylline; and health food products, such as Guoweikang Vitamin C tablets, Guoweikang B vitamin lozenges, etc. It also provides technology transfer and technical consulting services of biotechnology.
The company was founded in 2006 and is headquartered in Shijiazhuang, China. CSPC Innovation Pharmaceutical Co., Ltd. is a subsidiary of CSPC NBP Pharmaceutical Co., Ltd.
CSPC Innovation Pharmaceutical Co., Ltd.
| Country | China |
| Founded | 2006 |
| Industry | Packaged Foods |
| Sector | Consumer Staples |
| Employees | 2,369 |
| CEO | Long Dai |
Contact Details
Address: No. 62 Zhangju Road Shijiazhuang, 051430 China | |
| Phone | 86 311 8540 8700 |
| Website | xnwpharma.net |
Stock Details
| Ticker Symbol | 300765 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100003K04 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Bing Yao | Executive Chairman |
| Long Dai | GM, Chief Financial Officer and Director |
| Hong Chao Li | Head of Accounting |
| Wen Xu | Secretary and Director |
| Dr. Xiwu Hui | Deputy General Manager |